strategic fund

Congratulations to successful applicants

2025 Q4 Round

A total of 11 out of 29 applications were funded with $966,712 awarded in grants.

Jake Baum (UNSW Sydney) -  $100,000

Developing and testing in vivo mRNA encoded anti-malarial Monoclonal Vaccine therapies

Andrew Care (University of Technology Sydney) - $100,000

Building a NSW-RRTN RNA Manufacturing pipeline to accelerate product scale up and translation

Edmund Chung (University of Sydney) - $100,000

In-vivo generation of chimeric antigen receptor (CAR) T-cells using lipid nanoparticles to treat kidney disease

Jonas Kaltbeitzel (UNSW Sydney) - $51,000

Engineering in an Inosine-Specific RNase for sgRNA Synthesis and RNA modification mapping

Daniel Mediati (University of Technology Sydney) - $89,462

Programmable non-coding RNA-based regulatory circuits to tune cell wall synthesis and degradation rates

Lezanne Ooi (University of Wollongong) - $50,000

Advancing Splice-Switching RNA Therapeutics for Amyotrophic Lateral Sclerosis: Preclinical Development Toward Translation

Febrina Sandra (UNSW Sydney) - $100,000

Scalable Manufacturing of Nanobody Targeting Lipid Nanoparticles (tLNPs) for CAR-T and CAR-M Cell Therapy

Kurt Sengul (Macquarie University) - $100,000

Can the RNAissance Survive the Disinformation War? Emerging Threats, Transnational Challenges, Communicative Solutions

Jamie Triccas (University of Sydney) - $98,000

Development and Preclinical Validation of a Pulmonary RNA Vaccine Candidate for Tuberculosis

Rohan Walker (University of Newcastle) - $78,250

The Immunity Project: From Vaccine Production to Protection – Inspiring the Next Generation of Biomedical Innovators

Guoying Wang (Macquarie University) - $100,000

Transforming Glioblastoma Treatment through Targeted RNA Delivery and Blood–Brain Barrier Modulation

Subscribe to our mailing list using the button below for updates on the Network and our programs.